HALIFAX, NOVA SCOTIA and CALGARY, ALBERTA - November 5, 2009 - Shear Wind Inc. ("Shear Wind") (TSX VENTURE: SWX) announces the successful closing along with the final TSX Venture Exchange approval of the private placement with Genera Avante Holdings Canada Inc. ("GAHC")

Gold climbed on Tuesday after data showed the U.S. manufacturing sector grew more than expected in August, lifting appetite for assets seen as higher risk, such as commodities, and boosting inflation fears.

But gains were capped by a slight recovery in the U.S. dollar and by a reduction in the metal’s appeal as a haven.

Spot gold was bid at $954.40 an ounce at 1444 GMT, against $949.65 an ounce late in New York on Monday. U.S. gold futures for December delivery on the COMEX division of the New York Mercantile Exchange rose $2.70 to $956.20.

The data from the Institute of Supply Managers showed the U.S. manufacturing sector returned to growth in August after a prolonged slump, while pending home sales raced to a two-year high in July.

The news boosted U.S. stock markets, while European shares pared earlier losses.

Simon Weeks, head of precious metals at the Bank of Nova Scotia, said the news was

...

For Immediate Release

Chicago, IL - May 29, 2009 - Zacks.com releases the latest Industry Outlook. Today's interview is with senior analyst Chris Kallos, who talks about the Healthcare Industry, including BioScrip, Inc. (BIOS), WellPoint (WLP) and NovaMed Inc. (NOVA).

A synopsis of today's Industry Outlook is presented below. The full article can be read at http://at.zacks.com/?id=2678.

Health technology holds promise of improved operating efficiencies for many parts of the healthcare industry, hospitals included. However, in the short term those that stand to benefit the most from the stimulus are the companies whose business models are based on information technology platforms.

One such company is BioScrip, Inc. (BIOS) , a specialty pharmacy services provider and pharmacy benefit manager. Bioscrip operates two interrelated business segments, namely: Specialty Services, which is comprised of specialty pharmacy distribution and clinical management

...

Investor sentiment in healthcare continues to be driven by both Washington and the state of the broader economy.

In late February, President Obama released his administration's first budget proposal, which included the provision of a $630B reserve fund for healthcare reform over the next 10 years, financed in part by increases in taxes and changes to government program payments for physicians, hospitals and insurers (Medicare Advantage in particular). Details of the measure continue to evolve as discussions continue at the congressional level.

Earlier in February, the $787B economic stimulus package was passed in the Senate and House. The $150B in planned healthcare spending will include $25B towards the expansion of COBRA, $20B for health technology, and $85B for Medicaid assistance to states. The package clearly aims to improve the infrastructure of the healthcare industry and ultimately lower costs and expand access to more Americans.

OPPORTUNITIES

Health technology holds promise of improved operating efficiencies

...

Investor sentiment in healthcare continues to be driven by both Washington and the state of the broader economy.

In late February, President Obama released his administration's first budget proposal, which included the provision of a $630B reserve fund for healthcare reform over the next 10 years, financed in part by increases in taxes and changes to government program payments for physicians, hospitals and insurers (Medicare Advantage in particular). Details of the measure continue to evolve as discussions continue at the congressional level.

Earlier in February, the $787B economic stimulus package was passed in the Senate and House. The $150B in planned healthcare spending will include $25B towards the expansion of COBRA, $20B for health technology, and $85B for Medicaid assistance to states. The package clearly aims to improve the infrastructure of the healthcare industry and ultimately lower costs and expand access to more Americans.

OPPORTUNITIES

Health technology holds promise of improved operating efficiencies

...

Investor sentiment in healthcare continues to be driven by both Washington, DC and the state of the broader economy.In late February, President Obama released his administration's first budget proposal, which included the provision of a $630B reserve fund for healthcare reform over the next 10 years, financed in part by increases in taxes and changes to government program payments for physicians, hospitals and insurers (Medicare Advantage in particular). Details of the measure continue to evolve as discussions continue at the congressional level.Earlier in February, the $787B economic stimulus package was passed in the Senate and House. The $150B in planned healthcare spending will include $25B towards the expansion of COBRA, $20B for health technology, and $85B for Medicaid assistance to states. The package clearly aims to improve the infrastructure of the healthcare industry and ultimately lower costs and expand access to more Americans.OPPORTUNITIES...

Gold did virtually nothing from the Globex open in New York on Tuesday evening…right through until the Comex open in New York on Wednesday morning.

Then the selling pressure began in earnest. From the small vertical drops in price, it appeared that one or more not-for-profit sellers were pulling their bids…and each time they did…the price dropped vertically. These small waterfall declines are typical of the bullion banks. The bottom was in shortly before lunch in N.Y. From there the price rose slowly. Then at 2:15 the FOMC came forth with their two stone tablets and all hell broke loose. There was a gold price melt-up…as there were bids, but no ask…exactly the reverse of what happened earlier in the day. It made for a few exciting moments…and a great gold graph.

click to enlarge

In silver, the selloff

...

I was captivated by the Wall Street Journal headline “Bearish Big Investors Catch Gold Bug” by Gregory Zuckerman, because I don’t ever expect to see anything favorable about gold in the WSJ…

…since it is concerned primarily with providing information and news about stocks and bonds so that you will be motivated to constantly buy and sell stocks and bonds.

So I was surprised to read where it starts out with, “Large investors, including some who anticipated deep troubles for the housing and financial sectors, have been buying gold, concerned that moves by governments world-wide to shovel money at problem areas could cripple leading currencies.”

This is exactly true! That is exactly why I am buying gold, and why smart people are buying gold and why large investors are buying gold!

Well, since the WSJ is traditionally concerned with stocks and bonds and so is historically unconcerned and disdainful of gold, I figure

...

Gold didn’t do much in Far East trading until later in the day in Hong Kong. A small rally started that got hit shortly after London opened. Every little rally attempt [including the little one in Hong Kong] got sold off by some not-for-profit seller before it could develop any legs to the upside. The top in the gold price was at the London open…and the low of the day was at the London close. From the London close, gold rallied about $15 right into the close of electronic trading on the Globex at 5:15 in New York.

Silver, which I mentioned yesterday was the metal that the bullion banks are really after, got it in the neck again. It traded exactly the same as gold through Far East trading…smallish rally into the London open…hit for 30 cents…and then proceeded to trade sideways until the London p.m. gold fix. From that

...

NovaMed, Inc. (NOVA) is an emerging healthcare services company engaged in the operation of ambulatory surgery centers (ASCs) and the provision of optical products and services to eye-care professionals.The company reported better than expected 4Q08 net income of $2.40M (up 183%) or EPS of $0.10. An 8% y/y increase in net revenue from surgical facilities was primarily driven by recent acquisitions, which more than offset the 2% y/y decline in same facility revenue.We believe continuing strength of cash flows from operations offsets the significant increase in long-term debt as a result of 4Q08 acquisition activity, and retain our Buy recommendation at current levels. Our current 6-month target price is $5 per share.Read the full analyst report on NOVA\ "NOVA" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research